Involvement of DNA damage response pathways in hepatocellular carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Yang, Sheau Fang ^a,b   Chang, Chien Wei ^c,d   Wei, Ren Jie ^c,e,f   Shiue, Yow Ling ^f   Wang, Shen Nien ^b,d   Yeh, Yao Tsung ^c  

^a KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; ATM PROTEIN; C REACTIVE PROTEIN; CARCINOGEN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CISPLATIN; GLUTATHIONE PEROXIDASE; HISTONE H2AX; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KU ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MRE11 PROTEIN; NIBRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PACLITAXEL; PROTEIN KINASE C; PROTEIN P53; RAD50 PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; XRCC1 PROTEIN; DNA ADDUCT;

ALCOHOL CONSUMPTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE CHECKPOINT; CHROMOSOME ABERRATION; DIET; DNA ADDUCT; DNA DAMAGE; GENOMIC INSTABILITY; HEPATITIS B; HEPATITIS C; HUMAN; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; NONHUMAN; RADIOSENSITIVITY; REVIEW; RISK FACTOR; ANIMAL; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CHROMOSOME ABERRATIONS; DNA ADDUCTS; DNA DAMAGE; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84901351747     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/153867     Document Type: Review

References (259)

1. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
2. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
3. Buitrago-Molina L. E., Marhenke S., Longerich T., Sharma A. D., Boukouris A. E., Geffers R., Guigas B., Manns M. P., Vogel A., The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis. Hepatology 2013 58 3 1143 1152
4. Fortini P., Ferretti C., Dogliotti E., The response to DNA damage during differentiation: pathways and consequences. Mutation Research 2013 743-744 160 168
5. Ogara M. F., Sirkin P. F., Abel Carcagno L., Chromatin relaxation-mediated induction of p19INK4d increases the ability of cells to repair damaged DNA. PLoS ONE 2013 8 4 e61143
6. Lee Y. H., Kuo C. Y., Stark J. M., Shih H. M., Ann D. K., HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response. Nucleic Acids Research 2013 41 11 5784 5798
7. Chung Y. L., Wu M. L., Promyelocytic leukemia protein links DNA damage response and repair to hepatitis B virus related hepatocarcinogenesis. Journal of Pathology 2013 230 4 377 387
8. Bayram S., Akkiz H., Bekar A., Akgöllü E., Yildirim S., The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study. Molecular Biology Reports 2012 39 5 5943 5951 2-s2.0-84455188360 10.1007/s11033-011-1406-x
9. Hsu C. M., Yang M. D., Chang W. S., Jeng L. B., Lee M. H., Lu M. C., Chang S. C., Tsai C. W., Tsai Y., Tsai F. J., Bau D. T., The contribution of XRCC6/Ku70 to hepatocellular carcinoma in Taiwan. Anticancer Research 2013 33 2 529 535
10. Curtin N. J., DNA repair dysregulation from cancer driver to therapeutic target. Nature Reviews Cancer 2012 12 12 801 817
11. Lees-Miller S. P., Meek K., Repair of DNA double strand breaks by non-homologous end joining. Biochimie 2003 85 11 1161 1173 2-s2.0-0942268167 10.1016/j.biochi.2003.10.011 (Pubitemid 38142369)
12. El Idrissi M., Hervieu V., Merle P., Mortreux F., Wattel E., Cause-specific telomere factors deregulation in hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research 2013 32, article 64
13. Chen J., Zhang B., Wong N., Lo A. W., To K. F., Chan A. W., Ng M. H., Ho C. Y., Cheng S. H., Lai P. B., Yu J., Ng H. K., Ling M. T., Huang A. L., Cai X. F., Ko B. C., Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Research 2011 71 12 4138 4149
14. Zhang R.-G., Zhao J.-J., Yang L.-Q., Yang S.-M., Wang R.-Q., Chen W.-S., Peng G.-Y., Fang D.-C., RNA interference-mediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells. Oncology Reports 2010 23 4 1013 1019 2-s2.0-77949437834 10.3892/or-00000727
15. Chan T. H. M., Chen L., Liu M., Hu L., Zheng B.-J., Poon V. K.-M., Huang P., Yuan Y.-F., Huang J.-D., Yang J., Tsao G. S.-W., Guan X.-Y., Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. Hepatology 2012 55 2 491 505 2-s2.0-84856407376 10.1002/hep.24709
16. Martin-Lluesma S., Schaeffer C., Robert E. I., van Breugel P. C., Leupin O., Hantz O., Strubin M., Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008 48 5 1467 1476 2-s2.0-56149087784 10.1002/hep.22542
17. Yan H. X., Wu H. P., Zhang H. L., Ashton C., Tong C., Wu H., Qian Q. J., Wang H. Y., Ying Q. L., p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release. Journal of Hepatology 2013 59 4 762 768
18. Chung Y. L., Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen. The FASEB Journal 2013 27 6 2316 2327
19. Laurent-Puig P., Zucman-Rossi J., Genetics of hepatocellular tumors. Oncogene 2006 25 27 3778 3786 2-s2.0-33745532794 10.1038/sj.onc.1209547 (Pubitemid 43980473)
20. Schmitz K. J., Wohlschlaeger J., Lang H., Sotiropoulos G. C., Malago M., Steveling K., Reis H., Cicinnati V. R., Schmid K. W., Baba H. A., Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. Journal of Hepatology 2008 48 1 83 90 2-s2.0-36549013178 10.1016/j.jhep.2007.08.018 (Pubitemid 350191996)
21. Edamoto Y., Hara A., Biernat W., Terracciano L., Cathomas G., Riehle H.-M., Matsuda M., Fujii H., Scoazec J.-Y., Ohgaki H., Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. International Journal of Cancer 2003 106 3 334 341 2-s2.0-0038505659 10.1002/ijc.11254 (Pubitemid 36870393)
22. Koike K., Pathogenesis of HCV-associated HCC: dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling. Hepatology Research 2007 37 supplement 2 S115 S120
23. Dandri M., Burda M. R., Bürkle A., Zuckerman D. M., Will H., Rogler C. E., Greten H., Petersen J., Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology 2002 35 1 217 223 2-s2.0-0036140134 10.1053/jhep.2002.30203 (Pubitemid 34032563)
24. Kremsdorf D., Soussan P., Paterlini-Brechot P., Brechot C., Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006 25 27 3823 3833 2-s2.0-33745517203 10.1038/sj.onc.1209559 (Pubitemid 43980478)
25. Shaul Y., Garcia P. D., Schonberg S., Rutter W. J., Integration of hepatitis B virus DNA in chromosome-specific satellite sequences. Journal of Virology 1986 59 3 731 734 2-s2.0-0022500829 (Pubitemid 16011137)
26. Berger I., Shaul Y., Integration of hepatitis B virus: analysis of unoccupied sites. Journal of Virology 1987 61 4 1180 1186 2-s2.0-0023109645 (Pubitemid 17044032)
27. Salvucci M., Lemoine A., Azoulay D., Sebagh M., Bismuth H., Reynes M., May E., Debuire B., Frequent microsatellite instability in post hepatitis B viral cirrhosis. Oncogene 1996 13 12 2681 2685 2-s2.0-0030444515 (Pubitemid 27046123)
28. Karachristos A., Liloglou T., Field J. K., Deligiorgi E., Kouskouni E., Spandidos D. A., Microsatellite instability and p53 mutations in hepatocellular carcinoma. Molecular Cell Biology Research Communications 1999 2 3 155 161 2-s2.0-0033186531 (Pubitemid 129533212)
29. Dore M. P., Realdi G., Mura D., Onida A., Massarelli G., Dettori G., Graham D. Y., Sepulveda A. R., Genomic instability in chronic viral hepatitis and hepatocellular carcinoma. Human Pathology 2001 32 7 698 703 2-s2.0-0034910705 10.1053/hupa.2001.25593 (Pubitemid 32726894)
30. Kawai H., Suda T., Aoyagi Y., Isokawa O., Mita Y., Waguri N., Kuroiwa T., Igarashi M., Tsukada K., Mori S., Shimizu T., Suzuki Y., Abe Y., Takahashi T., Nomoto M., Asakura H., Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error. Hepatology 2000 31 6 1246 1250 2-s2.0-0034037032 (Pubitemid 30351285)
31. Kondo Y., Kanai Y., Sakamoto M., Mizokami M., Ueda R., Hirohashi S., Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis: a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000 32 5 970 979 2-s2.0-0033765496
32. Salvucci M., Lemoine A., Saffroy R., Azoulay D., Lepère B., Gaillard S., Bismuth H., Reynès M., Debuire B., Microsatellite instability in European hepatocellular carcinoma. Oncogene 1999 18 1 181 187 2-s2.0-0033531255 10.1038/sj.onc.1202279 (Pubitemid 29060592)
33. Macdonald G. A., Greenson J. K., Saito K., Cherian S. P., Appelman H. D., Richard Boland C., Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. Hepatology 1998 28 1 90 97 2-s2.0-0031835595 10.1002/hep.510280114 (Pubitemid 28299990)
34. Nozaki I., Ohashi R., Matsubara N., Hirai R., Andou A., Miyazaki M., Shimizu N., Namba M., Microsatellite instability correlates with normal expression of cyclin E in hepatocellular carcinomas. International journal of oncology 2001 18 6 1265 1269 2-s2.0-0035380773
35. Takagi K., Esumi M., Takano S., Iwai S., Replication error frequencies in primary hepatocellular carcinoma: a comparison of solitary primary versus multiple primary cancers. Liver 1998 18 4 272 276 2-s2.0-0031725801 (Pubitemid 28438535)
36. Yano M., Asahara T., Dohi K., Mizuno T., Iwamoto K. S., Seyama T., Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients. International Journal of Oncology 1999 14 3 447 451 2-s2.0-0033091728
37. Park Y. M., Choi J. Y., Bae S. H., Byun B. H., Ahn B. M., Kim B. S., Shin D. Y., Microsatellite instability and mutations of E2F-4 in hepatocellular carcinoma from Korea. Hepatology Research 2000 17 2 102 111 2-s2.0-0034024677 10.1016/S1386-6346(99)00066-2 (Pubitemid 30175935)
38. Martins C., Kedda M. A., Kew M. C., Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks. World Journal of Gastroenterology 1999 5 6 470 476 2-s2.0-0000522660
39. Laurent-Puig P., Legoix P., Bluteau O., Belghiti J., Franco D., Binot F., Monges G., Thomas G., Bioulac-Sage P., Zucman-Rossi J., Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001 120 7 1763 1773 2-s2.0-0034995765 (Pubitemid 32523494)
40. Wang L., Bani-Hani A., Montoya D. P., Roche P. C., Thibodeau S. N., Burgart L. J., Roberts L. R., hMLH1 and hMSH2 expression in human hepatocellular carcinoma. International journal of oncology 2001 19 3 567 570 2-s2.0-0035458842
41. Yamamoto H., Itoh F., Fukushima H., Kaneto H., Sasaki S., Ohmura T., Satoh T., Karino Y., Endo T., Toyota J., Imai K., Infrequent widespread microsatellite instability in hepatocellular carcinomas. International journal of oncology 2000 16 3 543 547 2-s2.0-18544400776
42. Kondo Y., Kanai Y., Sakamoto M., Mizokami M., Ueda R., Hirohashi S., Microsatellite instability associated with hepatocarcinogenesis. Journal of Hepatology 1999 31 3 529 536 2-s2.0-0033198382 10.1016/S0168-8278(99)80047-6 (Pubitemid 29408738)
43. Saeki A., Tamura S., Ito N., Kiso S., Matsuda Y., Yabuuchi I., Kawata S., Matsuzawa Y., Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients. Cancer 2000 88 5 1025 1029 (Pubitemid 30127661)
44. Piao Z., Kim H., Malkhosyan S., Park C., Frequent chromosomal instability but no microsatellite instability in hepatocellular carcinomas. International journal of oncology 2000 17 3 507 512 2-s2.0-0034266559
45. Roncalli M., Bianchi P., Grimaldi G. C., Ricci D., Laghi L., Maggioni M., Opocher E., Borzio M., Coggi G., Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up. Hepatology 2000 31 4 846 850 2-s2.0-0034025348 (Pubitemid 30169929)
46. Maggioni M., Coggi G., Cassani B., Bianchi P., Romagnoli S., Mandelli A., Borzio M., Colombo P., Roncalli M., Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 2000 32 5 942 946 2-s2.0-0033754784
47. Wang G., Zhao Y., Liu X., Wang L., Wu C., Zhang W., Liu W., Zhang P., Cong W., Zhu Y., Zhang L., Chen S., Wan D., Zhao X., Huang W., Gu J., Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes and Cancer 2001 31 3 221 227 2-s2.0-0034998462 10.1002/gcc.1138 (Pubitemid 32521752)
48. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y., Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Research 1990 50 22 7184 7189 2-s2.0-0025250745
49. Morita R., Ishikawa J., Tsutsumi M., Hikiji K., Tsukada Y., Kamidono S., Maeda S., Nakamura Y., Allelotype of renal cell carcinoma. Cancer Research 1991 51 3 820 823 2-s2.0-0025975990
50. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H., Yagura M., Matsubara K., Nakamura Y., Allelotype study of primary hepatocellular carcinoma. Cancer Research 1991 51 1 89 93 2-s2.0-0026022684
51. Yokoyama S., Yamakawa K., Tsuchiya E., Murata M., Sakiyama S., Nakamura Y., Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Research 1992 52 4 873 877 2-s2.0-0026593965
52. Miki Y., Nishisho I., Miyoshi Y., Horii A., Ando H., Nakajima T., Utsunomiya J., Nakamura Y., Frequent loss of heterozygosity at the MCC locus on chromosome 5q21-22 in sporadic colorectal carcinomas. Japanese Journal of Cancer Research 1991 82 9 1003 1007 2-s2.0-0025866137
53. Wogan G. N., Hecht S. S., Felton J. S., Conney A. H., Loeb L. A., Environmental and chemical carcinogenesis. Seminars in Cancer Biology 2004 14 6 473 486 2-s2.0-5444239783 10.1016/j.semcancer.2004.06.010 (Pubitemid 39360995)
54. Wild C. P., Montesano R., A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Letters 2009 286 1 22 28 2-s2.0-70449122418 10.1016/j.canlet.2009.02.053
55. Martin J., Dufour J.-F., Tumor suppressor and hepatocellular carcinoma. World Journal of Gastroenterology 2008 14 11 1720 1733 2-s2.0-41849083418 10.3748/wjg.14.1720 (Pubitemid 351493378)
56. Jackson P. E., Kuang S.-Y., Wang J.-B., Strickland P. T., Muñoz A., Kensler T. W., Qian G.-S., Groopman J. D., Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 2003 24 10 1657 1663 2-s2.0-0142154305 10.1093/carcin/bgg101 (Pubitemid 37304671)
57. Bressac B., Kew M., Wands J., Ozturk M., Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991 350 6317 429 431 2-s2.0-0025828517 10.1038/350429a0 (Pubitemid 21912246)
58. Montesano R., Hainaut P., Wild C. P., Hepatocellular carcinoma: from gene to public health. Journal of the National Cancer Institute 1997 89 24 1844 1851 2-s2.0-0031442701 (Pubitemid 28009820)
59. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C., Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991 350 6317 427 428 2-s2.0-0025732215 10.1038/350427a0 (Pubitemid 21912245)
60. Ozturk M., Bressac B., Puisieux A., Kew M., Volkmann M., Bozcall S., Mura J. B., De la Monte S., Carlson R., Blum H., Wands J., Takahashi H., Von Weizsacker F., Galun E., Kar S., Carr B. I., Schroder C. H., Erken E., Varinli S., p53 mutation in hepatocellular carcinoma after aflatoxin exposure. The Lancet 1991 338 8779 1356 1359 2-s2.0-0025748539 10.1016/0140-6736(91)92236-U
61. Stern M. C., Umbach D. M., Yu M. C., London S. J., Zhang Z.-Q., Taylor J. A., Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiology Biomarkers and Prevention 2001 10 6 617 625 2-s2.0-0034905993 (Pubitemid 32703195)
62. Egal S., Hounsa A., Gong Y. Y., Turner P. C., Wild C. P., Hall A. J., Hell K., Cardwell K. F., Dietary exposure to aflatoxin from maize and groundnut in young children from Benin and Togo, West Africa. International Journal of Food Microbiology 2005 104 2 215 224 2-s2.0-24744451814 10.1016/j.ijfoodmicro. 2005.03.004 (Pubitemid 41297490)
63. Obuseh F. A., Jolly P. E., Kulczycki A., Ehiri J., Waterbor J., Desmond R. A., Preko P. O., Jiang Y., Piyathilake C. J., Aflatoxin levels, plasma vitamins A and e concentrations, and their association with HIV and hepatitis B virus infections in Ghanaians: a cross-sectional study. Journal of the International AIDS Society 2011 14 1, article no. 53 2-s2.0-81055126970 10.1186/1758-2652-14-53
64. Lewis L., Onsongo M., Njapau H., Schurz-Rogers H., Luber G., Kieszak S., Nyamongo J., Backer L., Dahiye A. M., Misore A., DeCock K., Rubin C., Nyikal J., Njuguna C., Langat A., Kilei I. K., Tetteh C., Likimani S., Oduor J., Nzioki D., Kamau B. W., Onsongo J., Slutsker L., Mutura C., Mensah P., Kessel F., Park D. L., Trujillo S., Funk A., Geiseker K. E., Azziz-Baumgartner E., Gupta N., Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environmental Health Perspectives 2005 113 12 1763 1767 2-s2.0-29144481947 (Pubitemid 41794273)
65. Sutandyo N., Nutritional carcinogenesis. Acta medica Indonesiana 2010 42 1 36 42 2-s2.0-77957283864
66. Sharma R. A., Farmer P. B., Biological relevance of adduct detection to the chemoprevention of cancer. Clinical Cancer Research 2004 10 15 4901 4912 2-s2.0-4143078133 10.1158/1078-0432.CCR-04-0098 (Pubitemid 39099763)
67. Wang J.-S., Groopman J. D., DNA damage by mycotoxins. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 1999 424 1-2 167 181 2-s2.0-0033535416 10.1016/S0027-5107(99)00017-2 (Pubitemid 29101617)
68. Lieber C. S., Alcohol and the liver: 1994 update. Gastroenterology 1994 106 4 1085 1105 2-s2.0-0028350768 (Pubitemid 24109299)
69. Levi F., Cancer prevention: epidemiology and perspectives. European Journal of Cancer 1999 35 14 1912 1924 2-s2.0-0033402253 10.1016/S0959-8049(99) 00294-4 (Pubitemid 30026213)
70. Kubo S., Kinoshita H., Hirohashi K., Tanaka H., Tsukamoto T., Shuto T., Kuroki T., High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 1997 121 4 425 429 2-s2.0-0030998115 (Pubitemid 27184967)
71. Pöschl G., Seitz H. K., Alcohol and cancer. Alcohol and Alcoholism 2004 39 3 155 165 2-s2.0-17144457787 10.1093/alcalc/agh057 (Pubitemid 38578731)
72. Fang J.-L., Vaca C. E., Development of a32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA. Carcinogenesis 1995 16 9 2177 2185 2-s2.0-0028978679
73. Vaca C. E., Fang J.-L., Schweda E. K. H., Studies of the reaction of acetaldehyde with deoxynucleosides. Chemico-Biological Interactions 1995 98 1 51 67 2-s2.0-0028803002 10.1016/0009-2797(95)03632-V
74. Woo L. L., Egner P. A., Belanger C. L., Wattanawaraporn R., Trudel L. J., Croy R. G., Groopman J. D., Essigmann J. M., Wogan G. N., Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicological Sciences 2011 122 1 38 44 2-s2.0-79961010169 10.1093/toxsci/kfr087
75. Zhang Y. J., Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma. World Journal of Hepatology 2010 2 3 94 102
76. Berasain C., Castillo J., Perugorria M. J., Latasa M. U., Prieto J., Avila M. A., Inflammation and liver cancer: new molecular links. Annals of the New York Academy of Sciences 2009 1155 206 221 2-s2.0-61649106928 10.1111/j.1749-6632.2009.03704.x
77. Porta C., Riboldi E., Sica A., Mechanisms linking pathogens-associated inflammation and cancer. Cancer Letters 2011 305 2 250 262 2-s2.0-79955465043 10.1016/j.canlet.2010.10.012
78. Calle E. E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004 4 8 579 591 2-s2.0-3543072186 (Pubitemid 39025053)
79. Starley B. Q., Calcagno C. J., Harrison S. A., Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010 51 5 1820 1832 2-s2.0-77951456114 10.1002/hep.23594
80. Takamatsu S., Noguchi N., Kudoh A., Nakamura N., Kawamura T., Teramoto K., Igari T., Arii S., Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. Hepato-Gastroenterology 2008 55 82-83 609 614 2-s2.0-44349169446 (Pubitemid 351741512)
81. Ahima R. S., Osei S. Y., Leptin signaling. Physiology and Behavior 2004 81 2 223 241 2-s2.0-2442670123 10.1016/j.physbeh.2004.02.014 (Pubitemid 38670089)
82. Marra F., Leptin and liver fibrosis: a matter of fat. Gastroenterology 2002 122 5 1529 1532 2-s2.0-0036240891 (Pubitemid 34465194)
83. 2-dependent MAPK pathways. Journal of Biological Chemistry 2004 279 6 4292 4304 2-s2.0-1042289785 10.1074/jbc.M308351200 (Pubitemid 38199017)
84. Saxena N. K., Titus M. A., Ding X., Floyd J., Srinivasan S., Sitaraman S. V., Anania F. A., Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. The FASEB Journal 2004 18 13 1612 1614 2-s2.0-9444223845 10.1096/fj.04-1847fje (Pubitemid 39561650)
85. Ikejima K., Takei Y., Honda H., Hirose M., Yoshikawa M., Zhang Y.-J., Lang T., Fukuda T., Yamashina S., Kitamura T., Sato N., Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002 122 5 1399 1410 2-s2.0-0036234147 (Pubitemid 34465182)
86. Tsochatzis E., Papatheodoridis G. V., Hadziyannis E., Georgiou A., Kafiri G., Tiniakos D. G., Manesis E. K., Archimandritis A. J., Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scandinavian Journal of Gastroenterology 2008 43 9 1128 1136 2-s2.0-49949085308 10.1080/00365520802085387
87. Uygun A., Kadayifci A., Yesilova Z., Erdil A., Yaman H., Saka M., Deveci M. S., Bagci S., Gulsen M., Karaeren N., Dagalp K., Serum leptin levels in patients with nonalcoholic steatohepatitis. The American Journal of Gastroenterology 2000 95 12 3584 3589 2-s2.0-0033636915 10.1016/S0002-9270(00) 02090-6
88. Wang Y.-Y., Lin S.-Y., Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis. Hormone Research 2003 60 4 185 190 2-s2.0-0141958538 10.1159/000073231 (Pubitemid 37256065)
89. Li Z., Yuan W., Ning S., Li J., Zhai W., Zhang S., Role of leptin receptor (LEPR) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis B virus infection. Molecular Diagnosis and Therapy 2012 16 6 383 388
90. Saxena N. K., Sharma D., Ding X., Lin S., Marra F., Merlin D., Anania F. A., Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Research 2007 67 6 2497 2507 2-s2.0-34047250349 10.1158/0008-5472.CAN-06-3075 (Pubitemid 46548934)
91. Wiltrout R. H., Regulation and antimetastatic functions of liver-associated natural killer cells. Immunological Reviews 2000 174 63 76 2-s2.0-0034083566 (Pubitemid 30201379)
92. de Lalla C., Galli G., Aldrighetti L., Romeo R., Mariani M., Monno A., Nuti S., Colombo M., Callea F., Porcelli S. A., Panina-Bordignon P., Abrignani S., Casorati G., Dellabona P., Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. Journal of Immunology 2004 173 2 1417 1425 2-s2.0-3142687525 (Pubitemid 38924323)
93. Hussain S. P., Hofseth L. J., Harris C. C., Radical causes of cancer. Nature Reviews Cancer 2003 3 4 276 285 2-s2.0-0038352053 (Pubitemid 37328863)
94. Majano P. L., Garcia-Monzon C., Does nitric oxide play a pathogenic role in hepatitis C virus infection? Cell Death and Differentiation 2003 10 supplement 1 S13 S15 2-s2.0-0037274161 10.1038/sj.cdd.4401115 (Pubitemid 36511846)
95. Dedon P. C., Tannenbaum S. R., Reactive nitrogen species in the chemical biology of inflammation. Archives of Biochemistry and Biophysics 2004 423 1 12 22 2-s2.0-1042298162 10.1016/j.abb.2003.12.017 (Pubitemid 38202218)
96. Cadet J., Douki T., Ravanat J.-L., Oxidatively generated damage to the guanine moiety of DNA: mechanistic aspects and formation in cells. Accounts of Chemical Research 2008 41 8 1075 1083 2-s2.0-51649086880 10.1021/ar700245e
97. Neeley W. L., Essigmann J. M., Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chemical Research in Toxicology 2006 19 4 491 505 2-s2.0-33646080824 10.1021/tx0600043
98. West J. D., Marnett L. J., Endogenous reactive intermediates as modulators of cell signaling and cell death. Chemical Research in Toxicology 2006 19 2 173 194 2-s2.0-33644514643 10.1021/tx050321u
99. Wang Y., Bulky DNA lesions induced by reactive oxygen species. Chemical Research in Toxicology 2008 21 2 276 281 2-s2.0-41649091432 10.1021/tx700411g
100. Kato N., Yoshida H., Kioko Ono-Nita S., Kato J., Goto T., Otsuka M., Lan K.-H., Matsushima K., Shiratori Y., Omata M., Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000 32 2 405 412 2-s2.0-0033863120 (Pubitemid 30614674)
101. Novo E., Parola M., Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008 1 1
102. Wu J., Zern M. A., Hepatic stellate cells: a target for the treatment of liver fibrosis. Journal of Gastroenterology 2000 35 9 665 672 2-s2.0-0033781716 10.1007/s005350070045
103. Bataller R., Schwabe R. F., Choi Y. H., Yang L., Paik Y. H., Lindquist J., Qian T., Schoonhoven R., Hagedorn C. H., Lemasters J. J., Brenner D. A., NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 2003 112 9 1383 1394 2-s2.0-0347986777 10.1172/JCI200318212 (Pubitemid 38057692)
104. Budhu A., Xin W. W., The role of cytokines in hepatocellular carcinoma. Journal of Leukocyte Biology 2006 80 6 1197 1213 2-s2.0-33845420396 10.1189/jlb.0506297 (Pubitemid 44904957)
105. Leonardi G. C., Candido S., Cervello M., Nicolosi D., Raiti F., Travali S., Spandidos D. A., Libra M., The tumor microenvironment in hepatocellular carcinoma. International Journal of Oncology 2012 40 6 1733 1747
106. Pikarsky E., Porat R. M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Uriell-Shoval S., Galun E., Ben-Neriah Y., NF- B functions as a tumour promoter in inflammation-associated cancer. Nature 2004 431 7007 461 466 2-s2.0-4644324186 10.1038/nature02924 (Pubitemid 39329586)
107. Luedde T., Schwabe R. F., NF- B in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nature Reviews Gastroenterology and Hepatology 2011 8 2 108 118 2-s2.0-79751492851 10.1038/nrgastro.2010.213
108. Prosser C. C., Yen R. D., Wu J., Molecular therapy for hepatic injury and fibrosis: where are we? World Journal of Gastroenterology 2006 12 4 509 515 2-s2.0-33644895961 (Pubitemid 43380778)
109. Adachi T., Togashi H., Suzuki A., Kasai S., Ito J., Sugahara K., Kawata S., NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 2005 41 6 1272 1281 2-s2.0-20044393839 10.1002/hep.20719 (Pubitemid 40770279)
110. Pinzani M., Gesualdo L., Sabbah G. M., Abboud H. E., Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. Journal of Clinical Investigation 1989 84 6 1786 1793 2-s2.0-0024840085 (Pubitemid 20016182)
111. Pan H. Z., Liang J., Yu Z., Lun L. M., Li H., Wang Q., Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pacific Journal of Cancer Prevention 2011 12 11 2947 2950
112. Yuan T., Wei J., Luo J., Liu M., Deng S., Chen P., Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Digestive Diseases and Sciences 2012 57 9 2451 2457 2-s2.0-84860557136 10.1007/s10620-012-2192-6
113. Wang W., Dang S., Li Y., Sun M., Jia X., Wang R., Liu J., hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: a meta-analysis. PLoS ONE 2013 8 4 e60178
114. Puisieux A., Galvin K., Troalen F., Bressac B., Marcais C., Galun E., Ponchel F., Yakicier C., Ji J., Ozturk M., Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. The FASEB Journal 1993 7 14 1407 1413 2-s2.0-0027517726 (Pubitemid 23336171)
115. Cun Y., Dai N., Xiong C., Li M., Sui J., Qian C., Li Z., Wang D., Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model. PLoS ONE 2013 8 2 e55313
116. Liu Y., Hou N., Zhao F., Zhang Y., Yuan J., He X., Zhong H., HBV infection downregulated Mre11 expression and induced genome instability. Wei Sheng wu Xue Bao 2008 48 8 1031 1034 2-s2.0-66049162662
117. Machida K., Mcnamara G., Cheng K. T.-H., Huang J., Wang C.-H., Comai L., Ou J.-H. J., Lai M. M. C., Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. Journal of Immunology 2010 185 11 6985 6998 2-s2.0-78650667610 10.4049/jimmunol.1000618
118. Teoh N. C., Yock Y. D., Swisshelm K., Lehman S., Wright J. H., Haque J., Gu Y., Fausto N., Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology 2008 47 6 2078 2088 2-s2.0-46249134069 10.1002/hep.22194 (Pubitemid 351945574)
119. Assenmacher N., Hopfner K.-P., MRE11/RAD50/NBS1: complex activities. Chromosoma 2004 113 4 157 166 2-s2.0-6944226229 10.1007/s00412-004-0306-4 (Pubitemid 39409786)
120. Furuse M., Nagase Y., Tsubouchi H., Murakami-Murofushi K., Shibata T., Ohta K., Distinct roles of two separable in vitro activities of yeast Mre11 in mitotic and meiotic recombination. EMBO Journal 1998 17 21 6412 6425 2-s2.0-0032476658 10.1093/emboj/17.21.6412 (Pubitemid 28497813)
121. Lee J.-H., Paull T. T., ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005 308 5721 551 554 2-s2.0-17644409069 10.1126/science.1108297 (Pubitemid 40570585)
122. Jackson S. P., Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002 23 5 687 696 2-s2.0-0036261707 (Pubitemid 34567505)
123. Zha S., Boboila C., Alt F. W., Mre11: roles in DNA repair beyond homologous recombination. Nature Structural and Molecular Biology 2009 16 8 798 800 2-s2.0-68249150701 10.1038/nsmb0809-798
124. Song H., Hollstein M., Xu Y., p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biology 2007 9 5 573 580 2-s2.0-34247329362 10.1038/ncb1571 (Pubitemid 46696539)
125. Qadri I., Fatima K., Abdel-Hafiz H., Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiology 2011 11, article 48 2-s2.0-79952201309 10.1186/1471-2180-11-48
126. Wei W., Li B., Hanes M. A., Kakar S., Chen X., Liu L., S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Science Translational Medicine 2010 2 19 19 ra13 2-s2.0-77952963414 10.1126/scitranslmed.3000328
127. McKillop I. H., Moran D. M., Jin X., Koniaris L. G., Molecular Pathogenesis of Hepatocellular Carcinoma. Journal of Surgical Research 2006 136 1 125 135 2-s2.0-33750296975 10.1016/j.jss.2006.04.013 (Pubitemid 44634548)
128. Han J., Hankinson S. E., De Vivo I., Spiegelman D., Tamimi R. M., Mohrenweiser H. W., Colditz G. A., Hunter D. J., A Prospective Study of XRCC1 Haplotypes and Their Interaction with Plasma Carotenoids on Breast Cancer Risk. Cancer Research 2003 63 23 8536 8541 2-s2.0-0347626097 (Pubitemid 37549513)
129. Ide H., Kotera M., Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biological and Pharmaceutical Bulletin 2004 27 4 480 485 2-s2.0-7444266619 10.1248/bpb.27.480 (Pubitemid 41701830)
130. Zhang H., Mizumachi T., Carcel-Trullols J., Li L., Naito A., Spencer H. J., Spring P. M., Smoller B. R., Watson A. J., Margison G. P., Higuchi M., Fan C.-Y., Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis 2007 28 8 1629 1637 2-s2.0-34548100492 10.1093/carcin/bgm072 (Pubitemid 47289023)
131. Bose S., Tripathi D. M., Sukriti, Sakhuja P., Kazim S. N., Sarin S. K., Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene 2013 519 2 231 237
132. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.-R., Sugimura H., Nohmi T., Kasai H., Yokota J., Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998 16 25 3219 3225 2-s2.0-0032565998 (Pubitemid 28330419)
133. Friedberg E. C., How nucleotide excision repair protects against cancer. Nature Reviews Cancer 2001 1 1 22 33 2-s2.0-0035495386 (Pubitemid 33741878)
134. Wood R. D., DNA repair in eukaryotes. Annual Review of Biochemistry 1996 65 135 167 (Pubitemid 26250607)
135. Fautrel A., Andrieux L., Musso O., Boudjema K., Guillouzo A., Langouët S., Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma. Journal of Hepatology 2005 43 2 288 293 2-s2.0-21844444584 10.1016/j.jhep.2005.02.020 (Pubitemid 40956882)
136. Helal T. E. A., Khamis N. S., El-Sharkawy T. M., Nada O. H., Radwan N. A., Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt. APMIS 2010 118 12 934 940 2-s2.0-78649499912 10.1111/j.1600-0463.2010.02658.x
137. Leach F. S., Nicolaides N. C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki P., Sistonen P., Aaltonen L. A., Nystrom-Lahti M., Guan X.-Y., Zhang J., Meltzer P. S., Yu J.-W., Kao F.-T., Chen D. J., Cerosaletti K. M., Fournier R. E. K., Todd S., Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993 75 6 1215 1225 2-s2.0-0027145633 10.1016/0092-8674(93)90330-S (Pubitemid 24006117)
138. Papadopoulos N., Nicolaides N. C., Wei Y.-F., Ruben S. M., Carter K. C., Rosen C. A., Haseltine W. A., Fleischmann R. D., Fraser C. M., Adams M. D., Venter J. C., Hamilton S. R., Petersen G. M., Watson P., Lynch H. T., Peltomaki P., Mecklin J.-P., De la Chapelle A., Kinzler K. W., Vogelstein B., Mutation of a mutL homolog in hereditary colon cancer. Science 1994 263 5153 1625 1629 2-s2.0-0028350601 (Pubitemid 24128369)
139. Fishel R., Lescoe M. K., Rao M. R. S., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R., The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993 75 5 1027 1038 2-s2.0-0027742295 10.1016/0092-8674(93)90546-3 (Pubitemid 24014559)
140. Wani Y., Notohara K., Tsukayama C., Okada S., Reduced expression of hMLH1 and hMSH2 gene products in high-grade hepatocellular carcinoma. Acta Medica Okayama 2001 55 2 65 71 2-s2.0-0035319593 (Pubitemid 33605240)
141. Matsukura S., Miyazaki K., Yakushiji H., Ogawa A., Chen Y., Sekiguchi M., Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma. Journal of Surgical Oncology 2003 82 3 194 200 2-s2.0-0037374586 10.1002/jso.10209 (Pubitemid 36278268)
142. Matsukura S., Soejima H., Nakagawachi T., Yakushiji H., Ogawa A., Fukuhara M., Miyazaki K., Nakabeppu Y., Sekiguchi M., Mukai T., CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. British Journal of Cancer 2003 88 4 521 529 2-s2.0-0037463277 10.1038/sj.bjc.6600743 (Pubitemid 36363361)
143. Hussein M. R., Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Liver International 2004 24 6 552 560 2-s2.0-11144351630 10.1111/j.1478-3231.2004.0962.x (Pubitemid 40028606)
144. Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., Sekiguchi M., High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 1997 18 8 1631 1635 2-s2.0-0031427721 10.1093/carcin/18.8.1631 (Pubitemid 28134789)
145. Bhargava A., Raghuram G. V., Pathak N., Varshney S., Jatawa S. K., Jain D., Mishra P. K., Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radical Biology and Medicine 2011 51 9 1806 1814 2-s2.0-80053614206 10.1016/j.freeradbiomed.2011.08.009
146. Wang Y. J., Chen X. G., Xiao Z. Y., Liu G. T., Sun H., Induction of cell cycle arrest by GL331 via triggering an ATM-dependent DNA damage response in HepG2 cells. Journal of Asian Natural Products Research 2012 14 7 657 664
147. Wang H., Zuo B., Wang H., Ren L., Yang P., Zeng M., Duan D., Liu C., Li M., CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 2012 422 1 103 108
148. Fujimaki S., Matsuda Y., Wakai T., Sanpei A., Kubota M., Takamura M., Yamagiwa S., Yano M., Ohkoshi S., Aoyagi Y., Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling. Cancer Letters 2012 319 1 98 108 2-s2.0-84858082260 10.1016/j.canlet.2011.12.043
149. Hanel W., Moll U. M., Links between mutant p53 and genomic instability. Journal of Cellular Biochemistry 2012 113 2 433 439 2-s2.0-84855551714 10.1002/jcb.23400
150. You K.-R., Wen J., Lee S.-T., Kim D.-G., Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl)retinamide-induced oxidative stress in hepatoma cells. Journal of Biological Chemistry 2002 277 6 3870 3877 2-s2.0-0037040169 10.1074/jbc.M109284200 (Pubitemid 34968638)
151. Ng L. T., Chiang L.-C., Lin Y.-T., Lin C.-C., Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. The American Journal of Chinese Medicine 2006 34 1 125 135 2-s2.0-32544437231 10.1142/S0192415X06003692 (Pubitemid 43231407)
152. Langelier M. F., Pascal J. M., PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Current Opinion in Structural Biology 2013 23 1 134 143
153. Schreiber V., Dantzer F., Amé J.-C., De Murcia G., Poly(ADP-ribose): novel functions for an old molecule. Nature Reviews Molecular Cell Biology 2006 7 7 517 528 2-s2.0-33745867638 10.1038/nrm1963 (Pubitemid 44036457)
154. Lockett K. L., Hall M. C., Xu J., Zheng S., Berwick M., Chuang S.-C., Clark P. E., Cramer S. D., Lohman K., Hu J. J., The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Research 2004 64 17 6344 6348 2-s2.0-4344646721 10.1158/0008-5472.CAN-04- 0338 (Pubitemid 39129440)
155. Ye F., Cheng Q., Hu Y., Zhang J., Chen H., PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma. PLoS ONE 2012 7 5 e37446
156. Ko H.-L., Ren E.-C., Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair. Hepatology 2011 54 4 1190 1198 2-s2.0-80053297366 10.1002/hep.24502
157. Sherlock S., Viruses and hepatocellular carcinoma. Gut 1994 35 6 828 832 2-s2.0-0028241689 (Pubitemid 24193231)
158. Fujita N., Sugimoto R., Ma N., Tanaka H., Iwasa M., Kobayashi Y., Kawanishi S., Watanabe S., Kaito M., Takei Y., Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. Journal of Viral Hepatitis 2008 15 7 498 507 2-s2.0-44849129329 10.1111/j.1365-2893.2008.00972.x (Pubitemid 351798987)
159. Takayama T., Makuuchi M., Hirohashi S., Sakamoto M., Okazaki N., Takayasu K., Kosuge T., Motoo Y., Yamazaki S., Hasegawa H., Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. The Lancet 1990 336 8724 1150 1153 2-s2.0-0025155659 10.1016/0140-6736(90)92768-D (Pubitemid 20362906)
160. Feitelson M., Hepatitis B virus infection and primary hepatocellular carcinoma. Clinical Microbiology Reviews 1992 5 3 275 301 2-s2.0-0026777434
161. Becker S. A., Lee T.-H., Butel J. S., Slagle B. L., Hepatitis B virus X protein interferes with cellular DNA repair. Journal of Virology 1998 72 1 266 272 2-s2.0-0031985778 (Pubitemid 28048836)
162. Beasley R. P., Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988 61 10 1942 1956 2-s2.0-0023933449
163. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S., Hepatocellular carcinoma and hepatitis B virus. The Lancet 1981 2 8256 1129 1132 2-s2.0-0019451351 (Pubitemid 11029639)
164. Shafritz D. A., Shouval D., Sherman H. I., Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. The New England Journal of Medicine 1981 305 18 1067 1073 2-s2.0-0019791877 (Pubitemid 12234831)
165. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., Paterlini-Bréchot P., Bréchot C., Kremsdorf D., Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Research 2001 61 21 7803 7810 2-s2.0-0035502957 (Pubitemid 33049368)
166. Murakami Y., Saigo K., Takashima H., Minami M., Okanoue T., Bréchet C., Paterlini-Bréchot P., Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005 54 8 1162 1168 2-s2.0-22644435919 10.1136/gut.2004.054452 (Pubitemid 41025914)
167. Kim M., Lee H. C., Tsedensodnom O., Hartley R., Lim Y.-S., Yu E., Merle P., Wands J. R., Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/ β -catenin signaling pathway in hepatocellular carcinoma cells. Journal of Hepatology 2008 48 5 780 791 2-s2.0-40949086754 10.1016/j.jhep.2007.12.020
168. Wieland S., Thimme R., Purcell R. H., Chisari F. V., Genomic analysis of the host response to hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6669 6674 (Pubitemid 38586032)
169. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 (Pubitemid 37328697)
170. Taylor P. R., Martinez-Pomares L., Stacey M., Lin H. H., Brown G. D., Gordon S., Macrophage receptors and immune recognition. Annual Review of Immunology 2005 23 901 944 (Pubitemid 40563189)
171. Kolios G., Valatas V., Kouroumalis E., Role of Kupffer cells in the pathogenesis of liver disease. World Journal of Gastroenterology 2006 12 46 7413 7420 2-s2.0-33845899370 (Pubitemid 46017736)
172. Bohr V. A., Dianov G. L., Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 1999 81 1-2 155 160 2-s2.0-0032693322 10.1016/S0300-9084(99)80048-0
173. Aravalli R. N., Steer C. J., Cressman E. N. K., Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008 48 6 2047 2063 2-s2.0-58149376548 10.1002/hep.22580
174. Kim C.-M., Koike K., Saito I., Miyamura T., Jay G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991 351 6324 317 320 2-s2.0-0025907983 10.1038/351317a0 (Pubitemid 21896589)
175. Billet O., Grimber G., Levrero M., Seye K. A., Briand P., Joulin V., In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. Journal of Virology 1995 69 9 5912 5916 2-s2.0-0029129018
176. Dragani T. A., Manenti G., Farza H., Della Porta G., Tiollais P., Pourcel C., Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis 1990 11 6 953 956 2-s2.0-0025325248 (Pubitemid 20207348)
177. Lee T.-H., Finegold M. J., Shen R.-F., DeMayo J. L., Woo S. L. C., Butel J. S., Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 1990 64 12 5939 5947 2-s2.0-0025222293
178. Slagle B. L., Lee T. H., Medina D., Finegold M. J., Butel J. S., Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Molecular Carcinogenesis 1996 15 4 261 269 (Pubitemid 26146864)
179. Terradillos O., Billet O., Renard C.-A., Levy R., Molina T., Briand P., Buendia M. A., The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997 14 4 395 404 2-s2.0-0031035764 (Pubitemid 27087102)
180. Dandri M., Schirmacher P., Rogler C. E., Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. Journal of Virology 1996 70 8 5246 5254 2-s2.0-0029955711 (Pubitemid 26240697)
181. Schirmacher P., Rogler C. E., Dienes H. P., Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Archiv B: Cell Pathology Including Molecular Pathology 1993 63 2 71 89 2-s2.0-0027500295 (Pubitemid 23064482)
182. Feitelson M. A., Zhu M., Duan L.-X., London W. T., Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993 8 5 1109 1117 2-s2.0-0027157304 (Pubitemid 23129832)
183. Wang X. W., Forrester K., Yeh H., Feitelson M. A., Gu J.-R., Harris C. C., Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences of the United States of America 1994 91 6 2230 2234 2-s2.0-0001655748 (Pubitemid 24092077)
184. Prost S., Ford J. M., Taylor C., Doig J., Harrison D. J., Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. Journal of Biological Chemistry 1998 273 50 33327 33332 2-s2.0-0032509549 10.1074/jbc.273.50.33327 (Pubitemid 29005709)
185. Truant R., Antunovic J., Greenblatt J., Prives C., Cromlish J. A., Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology 1995 69 3 1851 1859 2-s2.0-0028855276
186. Matsuda Y., Wakai T., Kubota M., DNA damage sensor gamma-H2AX is increased in preneoplastic lesions of hepatocellular carcinoma. The Scientific World Journal 2013 2013 7 597095 10.1155/2013/597095
187. Canman C. E., Lim D.-S., Cimprich K. A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M. B., Siliciano J. D., Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998 281 5383 1677 1679 2-s2.0-0032508608 10.1126/science.281.5383.1677 (Pubitemid 28435584)
188. Kastan M. B., Lim D.-S., The many substrates and functions of ATM. Nature Reviews Molecular Cell Biology 2000 1 3 179 186 2-s2.0-0034576494
189. Wang W.-H., Hullinger R. L., Andrisani O. M., Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. Journal of Biological Chemistry 2008 283 37 25455 25467 2-s2.0-54449091313 10.1074/jbc.M801934200
190. Wu X.-Y., Qian J.-J., Lin Y., Zheng M.-H., Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint. European Journal of Cancer 2008 44 11 1596 1602 2-s2.0-46049113873 10.1016/j.ejca.2008.04.012
191. Yamazaki K., Masugi Y., Sakamoto M., Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor- β signaling in hepatocarcinogenesis. Digestive Diseases 2011 29 3 284 288 2-s2.0-80051768100 10.1159/000327560
192. Severi T., Ying C., Vermeesch J. R., Cassiman D., Cnops L., Verslype C., Fevery J., Arckens L., Neyts J., van Pelt J. F., Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Molecular and Cellular Biochemistry 2006 290 1-2 79 85 2-s2.0-33749171416 10.1007/s11010-006-9167-x (Pubitemid 44473237)
193. Li N., Grivennikov S. I., Karin M., The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 2011 19 4 429 431 2-s2.0-79953749145 10.1016/j.ccr.2011.03.018
194. Wong V. W.-S., Yu J., Cheng A. S.-L., Wong G. L.-H., Chan H.-Y., Chu E. S.-H., Ng E. K.-O., Chan F. K.-L., Sung J. J.-Y., Chan H. L.-Y., High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. International Journal of Cancer 2009 124 12 2766 2770 2-s2.0-65649111667 10.1002/ijc.24281
195. Arzumanyan A., Sambandam V., Clayton M. M., Choi S. S., Xie G., Diehl A. M., Yu D. Y., Feitelson M. A., Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Research 2012 72 22 5912 5920
196. Ferri C., Caracciolo F., Zignego A. L., La Civita L., Monti M., Longombardo G., Lombardini F., Greco F., Capochiani E., Mazzoni A., Mazzaro C., Pasero G., Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. British Journal of Haematology 1994 88 2 392 394 2-s2.0-0027944012 (Pubitemid 24318191)
197. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 1990 87 17 6547 6549
198. Machida K., Cheng K. T.-N., Sung V. M.-H., Shimodaira S., Lindsay K. L., Levinet A. M., Lai M.-Y., Lai M. M. C., Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proceedings of the National Academy of Sciences of the United States of America 2004 101 12 4262 4267 2-s2.0-1642488349 10.1073/pnas.0303971101 (Pubitemid 38405917)
199. Machida K., Cheng K. T.-H., Sung V. M.-H., Lee K. J., Levine A. M., Lai M. M. C., Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. Journal of Virology 2004 78 16 8835 8843 2-s2.0-3543122310 10.1128/JVI.78.16.8835-8843.2004 (Pubitemid 39025148)
200. Lai M. M. C., Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002 122 2 568 571 2-s2.0-0036163870 (Pubitemid 34117007)
201. Ohshima H., Bartsch H., Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 1994 305 2 253 264 2-s2.0-0028218474 10.1016/0027-5107(94)90245-3 (Pubitemid 24082901)
202. Okuda M., Li K., Beard M. R., Showalter L. A., Scholle F., Lemon S. M., Weinman S. A., Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002 122 2 366 375 2-s2.0-0036165333 (Pubitemid 34116988)
203. Maki A., Kono H., Gupta M., Asakawa M., Suzuki T., Matsuda M., Fujii H., Rusyn I., Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Annals of Surgical Oncology 2007 14 3 1182 1190 2-s2.0-34250160595
204. Mihm S., Fayyazi A., Ramadori G., Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology 1997 26 2 451 458 2-s2.0-0030744075 10.1002/hep.510260228 (Pubitemid 27328325)
205. Rahman M. A., Dhar D. K., Yamaguchi E., Maruyama S., Sato T., Hayashi H., Ono T., Yamanoi A., Kohno H., Nagasue N., Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clinical Cancer Research 2001 7 5 1325 1332 2-s2.0-0034906314 (Pubitemid 32708688)
206. Schweyer S., Mihm S., Radzun H. J., Hartmann H., Fayyazi A., Liver infiltrating t lymphocytes express interferon γ and inducible nitric Oxide synthase in chronic hepatitis C virus infection. Gut 2000 46 2 255 259 2-s2.0-0034023105 10.1136/gut.46.2.255 (Pubitemid 30305854)
207. Izzo F., Montella M., Orlando A. P., Nasti G., Beneduce G., Castello G., Cremona F., Ensor C. M., Holtzberg F. W., Bomalaski J. S., Clark M. A., Curley S. A., Orlando R., Scordino F., Korba B. E., Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis. Journal of Gastroenterology and Hepatology 2007 22 1 86 91 2-s2.0-33845635205 10.1111/j.1440-1746.2006.04463.x (Pubitemid 44953422)
208. Parasole R., Izzo F., Perrone F., Pignata S., Galati M. G., Leonardi E., Castiglione F., Orlando R., Castello G., Esposito G., Gallo C., Daniele B., Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Clinical Cancer Research 2001 7 11 3504 3509 2-s2.0-0035189701 (Pubitemid 33069987)
209. Izzo F., Cremona F., Delrio P., Leonardi E., Castello G., Pignata S., Daniele B., Curley S. A., Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Annals of Surgical Oncology 1999 6 2 178 185 2-s2.0-0032958169 (Pubitemid 29114282)
210. Choi S.-H., Hwang S. B., Modulation of the transforming growth factor- β signal transduction pathway by hepatitis C virus nonstructural 5A protein. Journal of Biological Chemistry 2006 281 11 7468 7478 2-s2.0-33646348166 10.1074/jbc.M512438200 (Pubitemid 43847519)
211. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J., Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 1991 88 6 2451 2455 (Pubitemid 21916435)
212. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K., Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences of the United States of America 1991 88 13 5547 5551 2-s2.0-0025991559 10.1073/pnas.88.13.5547 (Pubitemid 21914782)
213. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M., Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 1993 67 3 1385 1395 2-s2.0-0027476809 (Pubitemid 23067645)
214. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K., Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 1993 90 22 10773 10777 2-s2.0-0027515735 10.1073/pnas.90.22.10773 (Pubitemid 23347125)
215. Ariumi Y., Kuroki M., Dansako H., Abe K.-I., Ikeda M., Wakita T., Kato N., The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication. Journal of Virology 2008 82 19 9639 9646 2-s2.0-52649086846 10.1128/JVI.00351-08
216. Kennedy R. D., D'Andrea A. D., DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. Journal of Clinical Oncology 2006 24 23 3799 3808 2-s2.0-33747376928 10.1200/JCO.2005.05.4171 (Pubitemid 46622318)
217. Chen L., Yuan Y.-F., Li Y., Chan T. H. M., Zheng B.-J., Huang J., Guan X.-Y., Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 2011 60 4 534 543 2-s2.0-79952532633 10.1136/gut.2010.224071
218. Martin-Vilchez S., Lara-Pezzi E., Trapero-Marugán M., Moreno-Otero R., Sanz-Cameno P., The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Reviews in Medical Virology 2011 21 5 315 329 2-s2.0-80051925892 10.1002/rmv.699
219. Wang R., Zhao N., Li S., Fang J. H., Chen M. X., Yang J., Jia W. H., Yuan Y., Zhuang S. M., MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42. Hepatology 2013 58 2 642 653
220. Lencioni R., Chemoembolization for hepatocellular carcinoma. Seminars in Oncology 2012 39 4 503 509
221. Liu L., Ren Z.-G., Shen Y., Zhu X.-D., Zhang W., Xiong W., Qin Y., Tang Z.-Y., Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition. Cancer Science 2010 101 1 120 128 2-s2.0-71849114901 10.1111/j.1349-7006.2009.01363.x
222. Zhang J., Lan S. J., Liu Q. R., Liu J. M., Chen X. Q., Neuroglobin, a Novel Intracellular Hexa-Coordinated Globin, Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Raf/MAPK/Erk. Molecular Pharmacology 2013 83 5 1109 1119
223. Zhang Q., Bai X., Chen W., Ma T., Hu Q., Liang C., Xie S., Chen C., Hu L., Xu S., Liang T., Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis 2013 34 5 962 973
224. Farazi P. A., DePinho R. A., Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer 2006 6 9 674 687 2-s2.0-33747830764 10.1038/nrc1934 (Pubitemid 44286000)
225. Matsuda Y., Ichida T., Fukumoto M., Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies. Medical Molecular Morphology 2011 44 3 117 124 2-s2.0-81355123262 10.1007/s00795-011- 0547-2
226. Della Corte C., Colombo M., Surveillance for hepatocellular carcinoma. Seminars in Oncology 2012 39 4 384 398
227. Llovet J. M., Ricci S., Mazzaferro V., Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 2008 359 4 378 390
228. Prendergast Á. M., Cruet-Hennequart S., Shaw G., Barry F. P., Carty M. P., Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or γ -irradiation. Cell Cycle 2011 10 21 3768 3777 2-s2.0-80655133926 10.4161/cc.10.21.17972
229. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
230. Kim C.-H., Park S.-J., Lee S.-H., A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation. Journal of Pharmacology and Experimental Therapeutics 2002 303 2 753 759 2-s2.0-0036827964 10.1124/jpet.102.038505 (Pubitemid 35231252)
231. Guo X., Ba Y., Ma X., An J., Shang Y., Huang Q., Yang H., Chen Z., Xing J., A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular Carcinoma. PLoS ONE 2011 6 12 2-s2.0-83155191798 10.1371/journal.pone.0028404 e28404
232. Chen Y.-J., Lin C.-P., Hsu M.-L., Shieh H.-R., Chao N. K., Chao K. S. C., Sonic Hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner. International Journal of Radiation Oncology Biology Physics 2011 80 3 851 859 2-s2.0-79957566966 10.1016/j.ijrobp.2011.01.003
233. Chae S., Kim Y. B., Lee J.-S., Cho H., Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2012 302 9 G1016 G1024 2-s2.0-84860516137 10.1152/ajpgi.00449.2011
234. Chen H., Shao C., Shi H., Mu Y., Sai K., Chen Z., Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma. Journal of Neuro-Oncology 2007 82 3 257 262 2-s2.0-34247193528 10.1007/s11060-006-9290-2 (Pubitemid 46614387)
235. Martha K. R. M., Rosangkima G., Amenla L., Rongpi T., Prasad S. B., Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice. Fundamental and Clinical Pharmacology 2013 27 3 329 338 2-s2.0-84855180736 10.1111/j.1472-8206.2011.01019.x
236. Ueda S., Shirabe K., Morita K., Umeda K., Kayashima H., Uchiyama H., Soejima Y., Taketomi A., Maehara Y., Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma. Annals of Surgical Oncology 2011 18 4 1204 1211 2-s2.0-79955867544 10.1245/s10434-010-1414-4
237. Kuroda S., Urata Y., Fujiwara T., Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Medica Okayama 2012 66 2 83 92
238. Lee S. G., Rho H. M., Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene 2000 19 3 468 471 2-s2.0-0034688143 (Pubitemid 30077349)
239. Qadri I., Conaway J. W., Conaway R. C., Schaack J., Siddiqui A., Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10578 10583 2-s2.0-0029743407 10.1073/pnas.93.20.10578 (Pubitemid 26333029)
240. Wang M., Qin C., Zhu J., Yuan L., Fu G., Zhang Z., Yin C., Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA and Cell Biology 2010 29 6 303 311 2-s2.0-77953926931 10.1089/dna.2009.0969
241. Dong P., Karaayvaz M., Jia N., Kaneuchi M., Hamada J., Watari H., Sudo S., Ju J., Sakuragi N., Mutant p53 gain-of-function induces epithelial- mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene 2013 32 27 3286 3295
242. Gobert C., Skladanowski A., Larsen A. K., The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10355 10360 2-s2.0-0033621189 10.1073/pnas.96.18.10355 (Pubitemid 29422562)
243. Zhang X., Miao X., Liang G., Hao B., Wang Y., Tan W., Li Y., Guo Y., He F., Wei Q., Lin D., Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Research 2005 65 3 722 726 2-s2.0-13444306156 (Pubitemid 40216429)
244. Delia D., Paine M., Buscemi G., Savio C., Palmeri S., Lulli P., Carlessi L., Fontanella E., Chessa L., MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Human Molecular Genetics 2004 13 18 2155 2163 2-s2.0-5744246254 10.1093/hmg/ddh221 (Pubitemid 39377837)
245. Gatei M., Jakob B., Chen P., Kijas A. W., Becherel O. J., Gueven N., Birrell G., Lee J.-H., Paull T. T., Lerenthal Y., Fazry S., Taucher-Scholz G., Kalb R., Schindler D., Waltes R., Dörk T., Lavin M. F., ATM protein-dependent phosphorylation of Rad50 protein Regulates DNA repair and cell cycle control. Journal of Biological Chemistry 2011 286 36 31542 31556 2-s2.0-80052424280 10.1074/jbc.M111.258152
246. He J., Shi L. Z., Truong L. N., Lu C. S., Razavian N., Li Y., Negrete A., Shiloach J., Berns M. W., Wu X., Rad50 zinc hook is important for the Mre11 complex to bind chromosomal DNA double-stranded breaks and initiate various DNA damage responses. The Journal of Biological Chemistry 2012 287 38 31747 31756
247. Steffen J., Nowakowska D., Niwińska A., Czapczak D., Kluska A., Pitkowska M., Wiśniewska A., Paszko Z., Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. International Journal of Cancer 2006 119 2 472 475 2-s2.0-33745225487 10.1002/ijc.21853
248. Zuhlke K. A., Johnson A. M., Okoth L. A., Stoffel E. M., Robbins C. M., Tembe W. A., Salinas C. A., Zheng S. L., Xu J., Carpten J. D., Lange E. M., Isaacs W. B., Cooney K. A., Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer. Familial Cancer 2012 11 4 595 600
249. Kozlov S. V., Graham M. E., Jakob B., Tobias F., Kijas A. W., Tanuji M., Chen P., Robinson P. J., Taucher-Scholz G., Suzuki K., So S., Chen D., Lavin M. F., Autophosphorylation and ATM activation: additional sites add to the complexity. Journal of Biological Chemistry 2011 286 11 9107 9119 2-s2.0-79953183356 10.1074/jbc.M110.204065
250. Kozlov S. V., Graham M. E., Peng C., Chen P., Robinson P. J., Lavin M. F., Involvement of novel autophosphorylation sites in ATM activation. EMBO Journal 2006 25 15 3504 3514 2-s2.0-33747614605 10.1038/sj.emboj.7601231 (Pubitemid 44264861)
251. Bakkenist C. J., Kastan M. B., DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003 421 6922 499 506 2-s2.0-0037472924 10.1038/nature01368 (Pubitemid 36168436)
252. Rappold I., Iwabuchi K., Date T., Chen J., Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. Journal of Cell Biology 2001 152 3 613 620 2-s2.0-0035972194 (Pubitemid 34280146)
253. Mattsson Å., Lundstedt S., Stenius U., Exposure of HepG2 cells to low levels of PAH-containing extracts from contaminated soils results in unpredictable genotoxic stress responses. Environmental and Molecular Mutagenesis 2009 50 4 337 348 2-s2.0-65549160933 10.1002/em.20486
254. Yang X., Zou P., Yao J., Yun D., Bao H., Du R., Long J., Chen X., Proteomic dissection of cell type-specific H2AX-Interacting protein complex associated with hepatocellular Carcinoma. Journal of Proteome Research 2010 9 3 1402 1415 2-s2.0-77949785319 10.1021/pr900932y
255. Wang Z., Yan J., Lin H., Hua F., Wang X., Liu H., Lv X., Yu J., Mi S., Wang J., Hu Z. W., Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Hepatology 2013 57 5 1869 1881
256. Wang Z., Lin H., Hua F., Hu Z. W., Repairing DNA damage by XRCC6/KU70 reverses TLR4-deficiency-worsened HCC development via restoring senescence and autophagic flux. Autophagy 2013 9 6 925 927
257. Wei S., Xiong M., Zhan D.-Q., Liang B.-Y., Wang Y.-Y., Gutmann D. H., Huang Z.-Y., Chen X.-P., Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing s-phase arrest through a p53-dependent pathway. Carcinogenesis 2012 33 3 538 547 2-s2.0-84857946225 10.1093/carcin/bgr319
258. Yu Z.-J., Sui J.-G., Ding Y.-Q., Cao Z.-S., Zhou P.-K., Wu D.-C., Expression of DNA-PK in hepato- and cholangio-neoplasms and its significance. Chinese Journal of Hepatology 2004 12 11 652 655 2-s2.0-33846441717
259. Wu G., Xu L., Lin N., Liu B., UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1 or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines. BMC Cancer 2013 13, article 167 10.1186/1471-2407-13- 167